Clinical Trials Logo

Stage III Malignant Melanoma clinical trials

View clinical trials related to Stage III Malignant Melanoma.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT04056247 Recruiting - Clinical trials for Stage IV Non-small Cell Lung Cancer

Predicting Responsiveness in Oncology Patients Based on Host Response Evaluation During Anti Cancer Treatments

PROPHETIC
Start date: October 1, 2019
Phase:
Study type: Observational

This study will develop an algorithm of identifying patients with stage IV NSCLC and Melanoma who could benefit from cancer treatment they receive.

NCT ID: NCT00226408 Recruiting - Therapy Clinical Trials

Standard High-Dose Alpha Interferon Versus Intermittent High-Dose Alpha Interferon

Start date: November 2003
Phase: Phase 3
Study type: Interventional

The study protocol is being conducted to compare intermittent high-dose i.v. administation of interferon alpha-2b with the standard high-dose treatment by Kirkwood with distant metastasis free survival (DMFI) as a primary endpoint.